3 completed, 2 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow RRMS: new trials by email Literature Review of RRMS trials Research Report on RRMS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality? Early Cerebro-spinal MRI, Biomarker Assessment, Clinical and Neuropsychological Evaluations - Multiple Sclerosis, RRMS | Not applicable | Not yet recruiting | University Hospital, Strasbourg, France | 136 | 2026-09-01 | 2026-04-22 |
| Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis HP 13C pyruvate injection, MRI Scanner - Multiple Sclerosis, RRMS | Phase 2 | Recruiting | Ari Green | 40 | 2026-06-03 | 2026-06-08 |
| Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis Modified Yishen Daluo Yin formula - RRMS | Not yet recruiting | Ying Gao | 328 | 2025-07-01 | 2025-06-26 | |
| Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece Dimethyl Fumarate (DMF) - RRMS | Completed | Genesis Pharma CNS & Specialty | 455 | 2016-09-23 | 2021-07-28 | |
| Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis Observational - Multiple Sclerosis, RRMS | Completed | Novartis Pharmaceuticals | 414 | 2012-05-29 | 2017-11-17 | |
| POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler AIN457, Placebo - Relapsing-remitting Multiple Sclerosis, RRMS | Phase 2 | Completed | Novartis Pharmaceuticals | 73 | 2009-12-01 | 2015-02-27 |
Multiple Sclerosis (3) · Multiple Sclerosis, Relapsing-Remitting (2) · Conversion Disorder (1)
Autoimmune Diseases (4) · Autoimmune Diseases of the Nervous System (4) · Demyelinating Autoimmune Diseases, CNS (4) · Demyelinating Diseases (4) · Immune System Diseases (4) · Nervous System Diseases (4) · Mental Disorders (1) · Multiple Sclerosis (1) · Somatoform Disorders (1)
Dimethyl Fumarate (1) · Watchful Waiting (1) · secukinumab (1)
Novartis Pharmaceuticals (2) · Ari Green (1) · Genesis Pharma CNS & Specialty (1) · University Hospital, Strasbourg, France (1) · Ying Gao (1)
Czechia (2) · United States (2) · Australia (1) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Italy (1) · Netherlands (1) · Poland (1) · Russia (1) · Spain (1) · Switzerland (1) · Ukraine (1)
Ari Green, MD (1)
2009 (1), R01NS102156 (1)